Author(s): Garach Bhavikkumar D

Email(s): bhavik.garach146@gmail.com

DOI: Not Available

Address: Garach Bhavikkumar D
PhD Research Scholar, Department of Pharmacy, JJT University, Vidyanagari, Churu Jhunjhunu Road, Chudela, District-Jhunjhunu– 333001, Rajasthan, India
*Corresponding Author

Published In:   Volume - 5,      Issue - 1,     Year - 2013


ABSTRACT:
The goal of antihypertensive therapy is to abolish the risks associated with blood pressure (BP) elevation without adversely affecting quality of life. Control of hypertension and treatment of concomitant pathophysiologic conditions require use of multiple drugs. Unfortunately, most studies regarding hypertensive disease have focused on monotherapy. Available data suggest that at least 75% of patients will require combination therapy to achieve contemporary BP targets, and increasing emphasis is being placed on the practical tasks involved in consistently achieving and maintaining goal BP in clinical practice. Thus, our knowledge of combination therapy in the treatment of hypertension is to a great extent extrapolation from monotherapy. Drug selection is based on efficacy in lowering BP and in reducing cardiovascular (CV) end points including stroke, myocardial infarction, and heart failure. Although the choice of initial drug therapy exerts some effect on long-term outcomes, it is evident that BP reduction per se is the primary determinant of CV risk reduction. This combination therapy presents the pharmacologic rationale for choosing specific drug combinations, and review patient selection criteria for initial and secondary use. Angiotensin-converting enzyme (ACE) inhibitors and calcium antagonists combinations should be particularly efficacious in reducing hypertensive target organ disease. Both of these drug classes have been shown to reduce hypertensive heart disease, diminish microproteinuria, and the decline in renal function. With regard to hypertensive vascular disease, both ACE inhibitors and calcium antagonists have documented benefits.


Cite this article:
Garach Bhavikkumar D. The rationale of use of combination therapy in hypertensive patients. Research J. Pharmacology and Pharmacodynamics. 2013; 5(1): 19-26.


Recomonded Articles:

Author(s): Manasa K.S, Kuppast I.J, Kishan Kumar M.A , Akshara K

DOI: 10.5958/2321-5836.2016.00034.3         Access: Open Access Read More

Author(s): K. Rashid, C. Senthil Kumar, P. M. Mohammed Haleel

DOI: 10.5958/2321-5836.2017.00037.4         Access: Open Access Read More

Author(s): Madhavi Sahu, S. Prakash Rao

DOI: 10.5958/2321-5836.2018.00031.9         Access: Closed Access Read More

Author(s): Aakanksha Tiwari, Ravindra Singh, R. C. Tripathi

DOI: 10.5958/2321-5836.2017.00025.8         Access: Open Access Read More

Author(s): Pushpa A. Karale, Mahesh A. Karale, Mokshada C. Utikar

DOI: 10.5958/2321-5836.2018.00006.X         Access: Open Access Read More

Author(s): Shoaib Ahmad

DOI: 10.5958/2321-5836.2017.00017.9         Access: Open Access Read More

Author(s): S Rani, R Manavalan, D Kilimozhi.

DOI: Not Available         Access: Open Access Read More

Author(s): Madhavi T, Soosammajohn, Khambhoja S, Bincy Raj, Amit Kumar.

DOI: Not Available         Access: Open Access Read More

Author(s): VI Zalavadiya, VK Shah, DD Santani, MS Patel, JM Fosi, AK Chaudhary.

DOI: Not Available         Access: Open Access Read More

Author(s): Saudagar RB, Buchake VV, Bachhav RS.

DOI: Not Available         Access: Open Access Read More

Author(s): Dubey R D, Ahmad A R, Paroha S, Sahu P K, Verma S, Daharwal S J, Prasad Reddy S L N, Qureshi M S.

DOI: Not Available         Access: Open Access Read More

Author(s): SM Bhanushali, KM Modh, IS Anand, CN Patel , JB Dave.

DOI: Not Available         Access: Open Access Read More

Author(s): Amit Alexander, DK Tripathi, Ajazuddin, Mukesh Singh, Monesh Sahu, Swarna.

DOI: Not Available         Access: Open Access Read More

Author(s): Bhargava Vyasa

DOI: Not Available         Access: Open Access Read More

Author(s): Dhruv VK, Singh Sanat, Bansal AK, Shrivastava PK, Khan Q H, Sharma Raj.

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacology and Pharmacodynamics (RJPPD) is an international, peer-reviewed journal....... Read more >>>

RNI: Not Available                     
DOI: 10.5958 2321-5836 


Recent Articles




Tags